Minnaar C, Szigeti G, Szasz A
Cancers (Basel). 2024; 16(23).
PMID: 39682096
PMC: 11639953.
DOI: 10.3390/cancers16233908.
Wang X, Zhang H, XinZhang , Liu Y
Biomark Res. 2024; 12(1):98.
PMID: 39228005
PMC: 11373306.
DOI: 10.1186/s40364-024-00628-3.
Winter R, Amghar M, Wacker A, Bakos G, Tas H, Roscher M
Pharmaceuticals (Basel). 2024; 17(8).
PMID: 39204136
PMC: 11359268.
DOI: 10.3390/ph17081031.
Ser M, Webb M, Sener U, Campian J
J Immunother Precis Oncol. 2024; 7(2):97-110.
PMID: 38721406
PMC: 11075475.
DOI: 10.36401/JIPO-23-34.
Reilly R, Georgiou C, Brown M, Cai Z
EJNMMI Radiopharm Chem. 2024; 9(1):37.
PMID: 38703297
PMC: 11069497.
DOI: 10.1186/s41181-024-00266-y.
Melanoma Derived Exosomes Amplify Radiotherapy Induced Abscopal Effect via IRF7/I-IFN Axis in Macrophages.
Wang L, Shen K, Gao Z, Ren M, Wei C, Yang Y
Adv Sci (Weinh). 2024; 11(13):e2304991.
PMID: 38286661
PMC: 10987102.
DOI: 10.1002/advs.202304991.
Nanotechnology Applications in Breast Cancer Immunotherapy.
Wang R, Kumar P, Reda M, Wallstrum A, Crumrine N, Ngamcherdtrakul W
Small. 2023; 20(41):e2308639.
PMID: 38126905
PMC: 11493329.
DOI: 10.1002/smll.202308639.
Opportunities and challenges in combining immunotherapy and radiotherapy in esophageal cancer.
Zhang X, Cai X, Yan C
J Cancer Res Clin Oncol. 2023; 149(20):18253-18270.
PMID: 37985502
PMC: 10725359.
DOI: 10.1007/s00432-023-05499-z.
Radiotherapy combined with immunotherapy could improve the immune infiltration of melanoma in mice and enhance the abscopal effect.
Zheng Y, Liu X, Li N, Zhao A, Sun Z, Wang M
Radiat Oncol J. 2023; 41(2):129-139.
PMID: 37403355
PMC: 10326504.
DOI: 10.3857/roj.2023.00185.
Hepatocellular Carcinoma Showing Tumor Shrinkage Due to an Abscopal Effect.
Yano R, Hirooka M, Morita M, Okazaki Y, Nakamura Y, Imai Y
Intern Med. 2023; 63(2):241-246.
PMID: 37197962
PMC: 10864073.
DOI: 10.2169/internalmedicine.1844-23.
The abscopal effect of anti-CD95 and radiotherapy in melanoma.
Xu J, He J, He J, He Y, Zhang D, Kong R
Discov Oncol. 2023; 14(1):68.
PMID: 37191832
PMC: 10188694.
DOI: 10.1007/s12672-023-00682-7.
Challenges in the combination of radiotherapy and immunotherapy for breast cancer.
Zhang R, Clark S, Guo B, Zhang T, Jeansonne D, Jeyaseelan S
Expert Rev Anticancer Ther. 2023; 23(4):375-383.
PMID: 37039098
PMC: 10929662.
DOI: 10.1080/14737140.2023.2188196.
Brain metastasis in breast cancer: focus on genes and signaling pathways involved, blood-brain barrier and treatment strategies.
Chhichholiya Y, Ruthuparna M, Velagaleti H, Munshi A
Clin Transl Oncol. 2023; 25(5):1218-1241.
PMID: 36897508
DOI: 10.1007/s12094-022-03050-z.
Biological and clinical review of IORT-induced wound fluid in breast cancer patients.
Jeibouei S, Shams F, Mohebichamkhorami F, Sanooghi D, Faal B, Akbari M
Front Oncol. 2022; 12:980513.
PMID: 36479071
PMC: 9720171.
DOI: 10.3389/fonc.2022.980513.
Updates in combined approaches of radiotherapy and immune checkpoint inhibitors for the treatment of breast cancer.
Jungles K, Holcomb E, Pearson A, Jungles K, Bishop C, Pierce L
Front Oncol. 2022; 12:1022542.
PMID: 36387071
PMC: 9643771.
DOI: 10.3389/fonc.2022.1022542.
Mechanism of exosomes in the tumor microenvironment in the abscopal effect (Review).
Kuang G, Wang Z, Luo C, Luo J, Wang J
Int J Oncol. 2022; 62(1).
PMID: 36367187
PMC: 9699724.
DOI: 10.3892/ijo.2022.5450.
Exploiting radiation immunostimulatory effects to improve glioblastoma outcome.
Awada H, Paris F, Pecqueur C
Neuro Oncol. 2022; 25(3):433-446.
PMID: 36239313
PMC: 10013704.
DOI: 10.1093/neuonc/noac239.
Radiobiological effects of wound fluid on breast cancer cell lines and human-derived tumor spheroids in 2D and microfluidic culture.
Jeibouei S, Hojat A, Mostafavi E, Aref A, Kalbasi A, Niazi V
Sci Rep. 2022; 12(1):7668.
PMID: 35538133
PMC: 9091274.
DOI: 10.1038/s41598-022-11023-z.
Heterogeneous Heat Absorption Is Complementary to Radiotherapy.
Szasz A
Cancers (Basel). 2022; 14(4).
PMID: 35205649
PMC: 8870118.
DOI: 10.3390/cancers14040901.
Therapeutic Associations Comprising Anti-PD-1/PD-L1 in Breast Cancer: Clinical Challenges and Perspectives.
Ledys F, Kalfeist L, Galland L, Limagne E, Ladoire S
Cancers (Basel). 2021; 13(23).
PMID: 34885109
PMC: 8656936.
DOI: 10.3390/cancers13235999.